[1] |
International Diabetes Federation. IDF diabetes atlas-8th edition [EB/OL]. (2018-06-26)[2020-07-22]. http://www.idf.org/diabetesatlas.
|
[2] |
NCD Risk Factor Collaboration (NCD-RISC). Worldwide trends in diabetes since 1980:a pooled analysis of 751 population-based studies with 4.4 million participants[J]. Lancet, 2016, 387(10027):1513-1530.
|
[3] |
Marini MA,Fiorentino TV,Succurro E,et al.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals[J].PLoS One, 2017, 12(4):e0175547.
|
[4] |
Irini C, Sergentanis TN, Roxanne CN, et al. Model for risk-based screening of diabetic retinopathy in people with newly-diagnosed type 2 diabetes mellitus[J]. Invest Ophthalmol Vis Sci, 2017, 58(6): BIO99-BIO105.
|
[5] |
Hempe JM, Liu S, Myers L, et al.The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial[J]. Diabetes Care, 2015, 38(6):1067-1074.
|
[6] |
Ahn CH, Min SH, Lee DH, et al.Hemoglobin glycation index is associated with cardiovascular diseases in people with impaired glucose metabolism[J]. J Clin Endocrinol Metab, 2017, 102(8):2905-2913.
|
[7] |
中华医学会糖尿病学会. 中国2型糖尿病防治指南(2010年版)[J]. 中国医学前沿杂志,2011, 3(6): 54-104.
|
[8] |
中华人民共和国卫生部疾病控制司. 中国成人超重和肥胖症预防控制指南[M]. 北京:人民卫生出版社,2006:1-20.
|
[9] |
《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治,2019,19(1):6-49.
|
[10] |
中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志,2007,35(5):390-419.
|
[11] |
苏健,覃玉,沈冲,等.吸烟和戒烟行为与男性2型糖尿病血糖控制关系的研究[J].中华流行病学杂志,2017,38(11):1454-1459.
|
[12] |
陈晓正, 李珍梅, 林慧卿,等. 糖化血红蛋白变异指数与糖尿病视网膜病变的相关性研究[J]. 中国糖尿病杂志, 2018, 26(3):188-192.
|
[13] |
钟玉玲,凡豪志,张茹,等.糖化血红蛋白变异指数与糖尿病慢性并发症发生风险的相关性研究[J].中国全科医学,2020,23(3):276-280.
|
[14] |
陈媛,丘美娇.海口市区老年2型糖尿病患者并发症发生情况及血糖控制现状调查[J].华南预防医学,2019,45(2):176-178,182.
|
[15] |
盛忠奇, 张真稳. 糖化血红蛋白指数与2型糖尿病周围神经病变的相关性研究[J].中国现代医学杂志,2019,29(24):78-81.
|
[16] |
vanSteen SC, Woodward M, Chalmers J, et al. Haemoglobin glycation index and risk for diabetes-related complications in the action in diabetes and vascular disease: Preterax and diamicron modified release controlled evaluation (ADVANCE) trial[J]. Diabetologia, 2018,61(4):780-789.
|
[17] |
吴斌,许婧.血清HbA1c、INS在T2DM并发高尿酸血症的表达意义及相关性[J].分子诊断与治疗杂志,2020,12(9):1230-1233.
|
[18] |
魏明燕,王国杰,苏虹虹.2型糖尿病患者血糖控制情况与HbA1c、25-羟维生素D、脂肪代谢的关系[J].中国热带医学,2018,18(2):173-175.
|
[19] |
何汉琴,杨建军,兰梅,等.血清成纤维细胞生长因子-21水平与2型糖尿病患者下肢动脉粥样硬化关系[J].华南预防医学,2019,45(4):323-326.
|
[20] |
于晓濛, 贺维峰, 王宁. 糖化血红蛋白变异指数与糖尿病周围神经病变的相关性分析[J].中华实用诊断与治疗杂志, 2019, 33(12): 1194-1197.
|
[21] |
Park SY, Kim YA, Hong YH, et al.Up-regulation of the receptor for advanced glycation end products in the skin biopsy specimens of patients with severe diabetic neuropathy[J]. J Clin Neurol, 2014, 10(4): 334-341.
|